Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sodium chloride, quantity: 350.7 mg; sodium bicarbonate, quantity: 178.5 mg; potassium chloride, quantity: 46.6 mg; macrogol 3350, quantity: 13125 mg - powder, oral - excipient ingredients: acesulfame potassium; flavour - for effective relief from constipation, treatment of constipation, and treatment of faecal impaction defined as refractory constipation with faecal loading of the rectum and/or colon confirmed by the physical examination of the abdomen and rectum, in adults and children 12 years and over.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sodium chloride, quantity: 175.35 mg; sodium bicarbonate, quantity: 89.25 mg; potassium chloride, quantity: 23.3 mg; macrogol 3350, quantity: 6562.5 mg - powder, oral - excipient ingredients: acesulfame potassium; flavour - for effective relief from constipation and treatment of chronic constipation in adults and children aged 2 years and older. for resolving faecal impaction, defined as refractory constipation with faecal loading of the rectum, or the rectum and colon, confirmed by physical examination of abdomen and rectum, in adults and children 2 years and older. for prevention of recurrence of faecal impaction in children aged 2 years and older. use in children 2 years and older should be limited to 12 weeks except under medical supervision.

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

colorama pharmaceuticals ltd - macrogol '3350'; sodium; chloride; bicarbonate; potassium - powder for oral solution - 105gram/1litre ; 65mmol/1litre ; 53mmol/1litre ; 17mmol/1litre ; 5.4mmol/1litre

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - macrogol '3350'; sodium; chloride; bicarbonate; potassium - powder for oral solution - 105gram/1litre ; 65mmol/1litre ; 53mmol/1litre ; 17mmol/1litre ; 5.4mmol/1litre

Bèlgica - anglès - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - macrogol 13,125 g; potassium chloride 0,0466 g; sodium chloride 0,3507 g; sodium hydrogen carbonate 0,1785 g - powder for oral solution - 13,125 g - 351 mg - 179 mg - 47 mg - sodium chloride 350.7 mg; sodium bicarbonate 178.5 mg; potassium chloride 46.6 mg; macrogol 3350 13.125 g - macrogol, combinations

Japó - anglès - すりの適正使用協議会 RAD-AR Council, Japan

maruishi pharmaceutical. co., ltd. - macrogol ointment - white ointment

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

dendy pharmaceuticals pty ltd - macrogol 3350, quantity: 1 g/g - solution, powder for - excipient ingredients: - decrease/reduce/relieve constipation ; aperient/laxative ; helps reduce occurrence of constipation

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - macrogol 3350, quantity: 13125 mg; potassium chloride, quantity: 46.6 mg; sodium chloride, quantity: 350.7 mg; sodium bicarbonate, quantity: 178.5 mg - powder, oral - excipient ingredients: acesulfame potassium - for effective relief from constipation, treatment of constipation, and treatment of faecal impaction defined as refractory constipation with faecal loading of the rectum and/or colon confirmed by the physical examination of the abdomen and rectum, in adults and children 12 years and over.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - macrogol 3350, quantity: 6562.5 mg; sodium bicarbonate, quantity: 89.25 mg; potassium chloride, quantity: 23.3 mg; sodium chloride, quantity: 175.35 mg - powder, oral - excipient ingredients: acesulfame potassium - for effective relief from constipation and treatment of chronic constipation in adults and children aged 2 years and older. for resolving faecal impaction, defined as refractory constipation with faecal loading of the rectum, or the rectum and colon, confirmed by physical examination of abdomen and rectum, in adults and children 2 years and older. for prevention of recurrence of faecal impaction in children aged 2 years and older. use in children 2 years and older should be limited to 12 weeks except under medical supervision.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

key pharmaceuticals pty ltd - macrogol 3350, quantity: 1 g/g - powder - excipient ingredients: - for effective relief from constipation and treatment of chronic constipation. softens stools.